Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Medicine and Dentistry
Biological Marker
100%
Anti-Inflammatory Drug
100%
Anterior Cruciate Ligament Tear
100%
Anterior Cruciate Ligament Injury
83%
Placebo
83%
Osteoarthritis
66%
Patient-Reported Outcome
50%
Early Intervention
33%
Collagen Type 2
33%
Homeostasis
16%
Infection
16%
Randomized Controlled Trial
16%
Adverse Event
16%
Tumor Necrosis Factor
16%
Antiinflammatory Agent
16%
Rank Sum Test
16%
Interstitial Collagenase
16%
Kruskal Wallis Test
16%
Articular Cartilage
16%
Subjective Report
16%
Telopeptide
16%
Joint Aspiration
16%
Treatment Group
16%
Nursing and Health Professions
Biological Marker
100%
Placebo
83%
Anterior Cruciate Ligament Injury
83%
Osteoarthritis
66%
Patient-Reported Outcome
50%
Early Intervention
33%
Collagen Type 2
33%
Infection
16%
Adverse Event
16%
Tumor Necrosis Factor
16%
Rank Sum Test
16%
Kruskal Wallis Test
16%
Telopeptide
16%
Interstitial Collagenase
16%
Antiinflammatory Agent
16%
Joint Aspiration
16%
Treatment Group
16%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
100%
Biological Marker
100%
Placebo
83%
Anterior Cruciate Ligament Injury
83%
Osteoarthritis
66%
Collagen Type 2
33%
Randomized Controlled Trial
16%
Telopeptide
16%
Infection
16%
Adverse Event
16%
Tumor Necrosis Factor
16%
Antiinflammatory Agent
16%
Interstitial Collagenase
16%
Treatment Group
16%
Neuroscience
Anti-Inflammatory
100%
Placebo
100%
Collagen Type 2
40%
Randomized Controlled Trial
20%
Biochemical Cascade
20%
Anti-Inflammatory Agent
20%
Interstitial Collagenase
20%
Telopeptide
20%
Necrosis
20%